Collagen Diseases  >>  Remicade (infliximab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Remicade (infliximab) / J&J
NCT00207714: An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis

Completed
2
172
US
Golimumab, MTX, Placebo, Infliximab
Centocor, Inc., Centocor BV
Rheumatoid Arthritis
02/05
02/06
NCT00076726: A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis

Terminated
2
44
US
Infliximab
Centocor, Inc., The Cleveland Clinic
Giant Cell Arteritis
 
07/05
NCT01313520: A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)

Completed
2
61
Europe
Infliximab, SCH 215596, Remicade, Placebo
Merck Sharp & Dohme LLC
Arthritis, Rheumatoid
03/12
03/12

Download Options